ScholarIQanswers from OpenAlex & ORCID
Timothy F. Cloughesy
ResearcherPublications, citations & collaboration network
Timothy F. Cloughesy is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Timothy F. Cloughesy have?
ScholarIQindexed works
Timothy F. Cloughesy has 1,350 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Timothy F. Cloughesy have?
ScholarIQcitation count
Timothy F. Cloughesy has 64,423 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Timothy F. Cloughesy?
ScholarIQh-index
Timothy F. Cloughesy has an h-index of 128 in OpenAlex.
What is the i10-index of Timothy F. Cloughesy?
ScholarIQi10-index
Timothy F. Cloughesy has an i10-index of 468 in OpenAlex.
What is the ORCID of Timothy F. Cloughesy?
ScholarIQorcid
The ORCID for Timothy F. Cloughesy is on the source record.
What is the OpenAlex record for Timothy F. Cloughesy?
ScholarIQopenalex
The OpenAlex for Timothy F. Cloughesy is on the source record.
What are the most-cited papers on Timothy F. Cloughesy?
ScholarIQmost cited works
Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
Timothy F. Cloughesy, Aaron Mochizuki, Joey Orpilla, Willy Hugo, Alex Lee, Tom B. Davidson, Anthony Wang, Benjamin M. Ellingson, Julie Rytlewski, Catherine Sanders, Eric S. Kawaguchi, Lin Du, Gang Li, William H. Yong, Sarah Gaffey, Adam L. Cohen, Ingo K. Mellinghoff, Eudocia Q. Lee, David A. Reardon, Barbara O’Brien, Nicholas Butowski, Phioanh L. Nghiemphu, Jennifer Clarke, Isabel Arrillaga‐Romany, Howard Colman, Thomas Kaley, John de Groot, Linda M. Liau, Patrick Y. Wen, Robert M. Prins
Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma
Ingo K. Mellinghoff, Martin J. van den Bent, Deborah T. Blumenthal, Mehdi Touat, Katherine B. Peters, Jennifer Clarke, Joe Mendez, Shlomit Yust‐Katz, Liam Welsh, Warren Mason, François Ducray, Yoshie Umemura, Burt Nabors, Matthias Holdhoff, Andreas F. Hottinger, Yoshiki Arakawa, Juan Manuel Sepúlveda-Sánchez, Wolfgang Wick, Riccardo Soffietti, James Perry, Pierre Giglio, Macarena de la Fuente, Elizabeth A. Maher, Steven Schoenfeld, Dan Zhao, Shuchi S. Pandya, Lori Steelman, Islam Hassan, Patrick Y. Wen, Timothy F. Cloughesy
Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme
Albert Lai, Anh Tran, Phioanh L. Nghiemphu, Whitney B. Pope, Orestes E. Solis, Michael T. Selch, Emese Filka, William H. Yong, Paul S. Mischel, Linda M. Liau, Surasak Phuphanich, Keith L. Black, Scott Peak, Richard M. Green, Cynthia E. Spier, Tatjana Kolevska, Jonathan Polikoff, Louis Fehrenbacher, Robert M. Elashoff, Timothy F. Cloughesy
Evidence for Sequenced Molecular Evolution of <i>IDH1</i> Mutant Glioblastoma From a Distinct Cell of Origin
Albert Lai, Samir Kharbanda, Whitney B. Pope, Anh Tran, Orestes E. Solis, Franklin Peale, William F. Forrest, Kanan Pujara, Jose Carrillo, Ajay Pandita, Benjamin M. Ellingson, Chauncey W. Bowers, Robert Soriano, Nils Ole Schmidt, Sankar Mohan, William H. Yong, Somasekar Seshagiri, Zora Modrušan, Zhaoshi Jiang, Kenneth Aldape, Paul S. Mischel, Linda M. Liau, Cameron Escovedo, Weidong Chen, Phioanh L. Nghiemphu, C. David James, Michael D. Prados, Manfred Westphal, Katrin Lamszus, Timothy F. Cloughesy, Heidi Phillips
Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.
Wei Chen, Timothy F. Cloughesy, Nirav Kamdar, Nagichettiar Satyamurthy, Marvin Bergsneider, Linda M. Liau, Paul S. Mischel, Johannes Czernin, Michael E. Phelps, Daniel Silverman